NASHVILLE, Tenn.–(BUSINESS WIRE<\/a>)– This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210810005917\/en\/<\/a><\/p>\n \n\u201cWe are pleased to report that the second quarter of 2021 was our best financial quarter in company history, including new records in revenues, cash flow from operations, Adjusted EBITDA(1)<\/sup>, revenue per shipping day, and units shipped,\u201d said Mark L. Baum, CEO of Harrow Health. \u201cDuring the second quarter of 2021, we strengthened our cash position by raising $75 million of unsecured capital. We then began to put that capital to work in a number of ways, including purchasing rights to AMP-100, a patented, ophthalmic topical anesthetic drug candidate, in July 2021. We expect a new drug application to be submitted to the FDA for AMP-100 in the next few months. In addition, our pipeline of potential strategic product opportunities continues to advance, and we are making significant progress on other potential M&A transactions. We remain excited about the second half of 2021 as we position Harrow to be able to deliver a more diverse range of products to our prescribers and attractive operational results to our stockholders.\u201d\n<\/p>\n (1)<\/sup> A reconciliation of all non-GAAP financial results can be found later in this release.\n<\/p>\n Conference Call and Webcast
\nHarrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced record results for the second quarter and first half ended June 30, 2021. The Company also posted its second quarter Letter to Stockholders<\/a> and corporate presentation<\/a> to the \u201cInvestors\u201d section of its website, harrowinc.com<\/a>.\n<\/p>\n
\n
<\/b>The Company\u2019s management team will host a conference call and live webcast today at 4:45 p.m. Eastern time to discuss the results and provide a business update. To participate in the call, see details below:\n<\/p>\n
![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20210810005917\/en\/1153477\/3\/HROW_Logo.jpg\"){kind=logo}
<\/td>\n<\/tr>\n